T0	Participants 57 126	external genital and perianal warts in different patient populations.
T1	Participants 324 355	patients' demographic variables
T2	Participants 440 476	external genital and perianal warts.
T3	Participants 490 530	Male and female immunocompetent patients
T4	Participants 979 1119	subgroups based on variables of gender, baseline wart area, duration of current outbreak of warts, previous wart treatment, and tobacco use.
T5	Participants 1317 1352	external genital and perianal warts